Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. EMEA Innovative Medicine /
    2. New Data Show Symptom Improvement Within One Week For Patients With Moderately To Severely Active Crohn’s Disease Treated With Stelara® (Ustekinumab)

    New Data Show Symptom Improvement Within One Week For Patients With Moderately To Severely Active Crohn’s Disease Treated With Stelara® (Ustekinumab)

    New Data Show Symptom Improvement Within One Week For Patients With Moderately To Severely Active Crohn’s Disease Treated With Stelara® (Ustekinumab)